Your browser doesn't support javascript.
loading
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts.
Tan, C Sabrina; Collier, Ai-Ris Y; Yu, Jingyou; Liu, Jinyan; Chandrashekar, Abishek; McMahan, Katherine; Jacob-Dolan, Catherine; He, Xuan; Roy, Vicky; Hauser, Blake M; Munt, Jennifer E; Mallory, Michael L; Mattocks, Melissa; Powers, John M; Meganck, Rita M; Rowe, Marjorie; Hemond, Rachel; Bondzie, Esther A; Jaegle, Kate H; Baric, Ralph S; Schmidt, Aaron G; Alter, Galit; Le Gars, Mathieu; Sadoff, Jerald; Barouch, Dan H.
Afiliação
  • Tan CS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Collier AY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • McMahan K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • He X; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Roy V; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge.
  • Hauser BM; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge.
  • Munt JE; University of North Carolina, Chapel Hill.
  • Mallory ML; University of North Carolina, Chapel Hill.
  • Mattocks M; University of North Carolina, Chapel Hill.
  • Powers JM; University of North Carolina, Chapel Hill.
  • Meganck RM; University of North Carolina, Chapel Hill.
  • Rowe M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Hemond R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Bondzie EA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Jaegle KH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Baric RS; University of North Carolina, Chapel Hill.
  • Schmidt AG; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge.
  • Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge.
  • Le Gars M; Janssen Vaccines and Prevention, Leiden, Netherlands.
  • Sadoff J; Janssen Vaccines and Prevention, Leiden, Netherlands.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
JAMA Netw Open ; 5(8): e2226335, 2022 08 01.
Article em En | MEDLINE | ID: mdl-35947380

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Netw Open Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Netw Open Ano de publicação: 2022 Tipo de documento: Article